Why attend? | Kisaco Research

Why attend?

2nd Annual Microbiome Connect: ASIA 2024
19-20 June, 2024
Seoul, Republic of Korea

Learn

Explore 2 full days of content & meet the CEOs leading the microbiome industry movement. Deep dive into the most need-to-know discovery, clinical, manufacturing, and commercial developments across a range of live biotherapeutic modalities and uncover emerging analytical strategies. Discover how novel approaches are tackling un-met patient needs in oncology, neuroscience, and metabolic disease.

Connect

Engage in conversations with 200 thought leaders and experts, with our 1-2-1 meeting system that maximises your networking potential. We attract the entire ecosystem from investors to biotechs, and regulators to academics, making this the number 1 place for therapeutic innovation.

Enjoy

The conference programme is just the start. Alongside presentations and partnering opportunities, we’re bringing you a host of interactive & informal activities to make sure you leave feeling energized & enlightened. After a momentous year for the field, take a breath and celebrate industry achievements amongst your peers.

Who's Going? Everyone!

For the last seven years, we’ve been running microbiome events across Europe, North America & Asia – after a phenomenal inaugural conference in Seoul last year, we’re thrilled to be bringing you the 2nd Microbiome Connect Asia Summit.

Are you ready to join us in 2024?

Every Challenge. Every Role. We’ve got you covered.

From CEOs to Professors, from Investors to Research Scientists, and whatever your modality – there’s a path for you at Microbiome Connect that will enable you to meet your research goals.

We cover:

  • Emerging therapeutic modalities including live-biotherapeutics, GM-bacteria, microbiome modulators, advanced-biotics and FMT.

  • Innovative microbial analysis techniques including metabolomics and multi-omics to define mechanism-of-action.

  • New opportunities to tackle un-met patient needs in oncology, neurological disorders, and diabetes.

VIEW THE PROGRAM

Drug Developers

A great platform to discuss the currently most relevant microbiome topics – a must for microbiome drug developers” – PharmaBiome

Biotechs are at the heart of the event – and as part of Microbiome Connect, you’ll join a global community of microbiome specialists committed to accelerating the development & approval of microbiome-based products to address unmet medical needs.

The landscape of microbiome drug development is constantly evolving, and it’s vital to stay up to date with what’s happening so that you can help shape what’s coming next. From the big-picture trends in regulation, investment and commercialization through to the critical details impacting each stage of the drug development process, our expert contributors will provide valuable insights into how you can move your business forward. Plus, we’ll connect you with the strategic partners you need to help take your innovation from concept to market.


5 Reasons to choose Microbiome Connect

  1. Made with industry, for industry, the agenda is specifically designed to address the strategic and research goals of microbiome biotechs, ensuring you & your team gain the tools, connections & intel you need to fast-track your product development
  2. Be in the room with leading life sciences investors who attend Microbiome Connect to find new portfolio companies – ensuring you access the capital you need for your business to thrive
  3. Spark the connections you need with our Partnering Platform, making it easier than ever to meet the right people for your research & business needs
  4. Sitting in the sweet spot between pure science and pure business, you can trust that you’ll hear the latest data & case studies from top biotechs & academics, as well as network with the most senior decision-makers from across the ecosystem
  5. We know that often your pipeline is built around several disease areas – and instead of needing to attend multiple disease-specific events across the year, you can gather all the insights you need in one place.

I'M INTERESTED

Investors

We firmly believe that microbiome products should be your next investment – and that’s why for 2024, qualified life sciences and healthcare investors can attend Microbiome Connect for free through our Investor Forum.


As part of the Investor Forum, you’ll benefit from:

Market Insights

Engage with strategic partners and a range of investment companies to understand the true potential of microbiome therapeutics. Join our community of investors with a shared interest in the human microbiome. COLLECT YOUR FREE INVESTOR PASS HERE

Preclinical & Clinical Validation

We select the leading APAC companies to present their latest breakthroughs on-stage. Ranging from laboratory based mechanism-of-action analyses to clinical efficacy studies; you will receive extensive data presentations transforming the field of microbiome drug development. .


Therapeutic Coverage

By covering the breadth of the microbiome industry, you’ll be able to build your conference agenda around your current investment priorities – no matter the disease area or modality.

1-2-1 Partnering

An investor who receives complimentary registration is expected to participate in the 1-2-1 partnering, with at least two meetings secured through the system with microbiome companies – allowing you to meet the leading biotechs in the space actively looking for early and late-stage investment in an efficient way. Our in-depth registration forms allow you to identify & target the most suitable prospects for you based on stage of development, strategic goals and therapeutic preferences.

Book a Free Investor Pass

Academics

Connect with scientists as passionate about the microbiome as you are – helping you take your innovative research to the next level. Microbiome Connect is the place for microbial innovators from across the globe to come together to networking & learn, with the ultimate goal to truly harness the therapeutic power of the microbiome.

Showcase your breakthrough research to our audience of experts who can guide you as you look to turn your work from a concept to a commercial product – from synthetic biology to novel organ models, from new clinical results to delivery mechanisms. APPLY FOR POSTER SHOWCASE HERE. Deadline for submissions: April 12 2024. Submit before March 15 for 10% off tickets.

The author of the best poster will receive one hour of mentorship time to guide you in making the most of your novel technology.


5 Reasons to choose Microbiome Connect

  1. Our agenda is built after intense research with the community, and is specifically designed to address the strategic & research goals of microbiome leaders, ensuring you gain the connections & intel you need to fast-track your R&D
  2. Be in the room with leading life sciences investors who attend Microbiome Connect to find the next innovation – ensuring you access the capital you need to transition from academia to industry
  3. Spark the connections you need with our Partnering Platform, making it easier than ever to meet the right people for your research & business needs
  4. Sitting in the sweet spot between pure science and pure business, you can trust that you’ll hear the latest data & case studies from top biotechs & academics, as well as network with the most senior decision-makers from across the ecosystem
  5. Thrive in a global microbiome community, with attendees from across the world coming together in Seoul to share insights that could transform microbiology


TELL ME MORE

Pharma

At Microbiome Connect, we know that the potential of the microbiome to treat un-met patient disease is almost limitless with clinical data pointing to significant value in gastroenterology, oncology, neurology, and metabolic disease. This is your opportunity to guide the industry with your R&D priorities and breakthroughs.

I'D LIKE TO FIND OUT MORE

  1. Present your latest microbiome scientific findings across your therapeutic pipelines, whether you’re utilizing biome-based biomarkers, harnessing bacteria for drug delivery or developing your own microbiome therapeutics get in touch about presenting your R&D breakthroughs 
  2. With new analytical capabilities, clinical evidence of microbiome therapeutic efficacy has never been greater, this is your opportunity to source external innovation as we platform the leading microbiome drug developers across the APAC region.
  3. With microbiome therapeutic predicted to be one of the fastest growing novel drug modalities of the decade, gather insights on market trends, R&D advancements, commercial viability and manufacturing techniques to inform your business decisions and pipeline strategy.

Other events you might be interested in:

Microbiome Connect: USA 2024

Microbiome Connect: Europe 2023